Home/Filings/4/0000899243-22-005931
4//SEC Filing

Hunt Hazel 4

Accession 0000899243-22-005931

CIK 0001088856other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 6:42 PM ET

Size

5.5 KB

Accession

0000899243-22-005931

Insider Transaction Report

Form 4
Period: 2022-02-02
Hunt Hazel
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-02+200,000200,000 total
    Exercise: $19.26Exp: 2032-02-01Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 2, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on February 2, 2026.

Issuer

CORCEPT THERAPEUTICS INC

CIK 0001088856

Entity typeother

Related Parties

1
  • filerCIK 0001698307

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:42 PM ET
Size
5.5 KB